DIPK2B: A Potential Drug Target and Biomarker for Divergent Protein Kinase Domain 2B-Controlled Metabolism

Target Name: DIPK2B

NCBI ID: G79742

DIPK2B

DIPK2B: A Potential Drug Target and Biomarker for Divergent Protein Kinase Domain 2B-Controlled Metabolism

Introduction

Divergent protein kinase domain 2B (ISOform 2) is a highly conserved protein that plays a critical role in various cellular processes, including cell signaling, metabolism, and stress response. The DIPK2B gene has four splice variants, each generating a unique isoform with different protein levels and functions. Despite its importance, DIPK2B has remained a relatively unstudied protein.

Recent studies have identified DIPK2B as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. In this article, we will explore the biology and functions of DIPK2B and its potential as a drug target and biomarker.

Biology and Functions of DIPK2B

DIPK2B is a 120-kDa protein that contains a unique N-terminal Divergent protein kinase domain, a catalytic center, and a C-terminal T-loop region. The DIPK2B protein is involved in various cellular processes, including cell signaling, DNA replication, and metabolism.

The DIPK2B protein is a non-synonymous splicing isoform (2), which means that it arises from a specific exonic sequence that is not present in any of the parent isoforms. Despite its unique nature, DIPK2B is highly conserved and has been shown to have similar protein structures to other D divergent protein kinases, such as DYK1 and DYK3.

DIPK2B functions as a negative regulator of the RAS/MAPK signaling pathway, which is involved in various cellular processes, including cell growth, differentiation, and survival. The RAS/MAPK pathway is a highly conserved signaling pathway that regulates various cellular processes , including cell signaling, angiogenesis, and inflammation. DIPK2B functions as a negative regulator of this pathway by atidylinositol (PI) levels and affecting the activity of the MAPK/ERK signaling pathway.

DIPK2B is involved in the regulation of cellular processes that are critical for cell survival, including cell growth, apoptosis, and stress response. It has been shown to play a role in various cellular stress responses, including the regulation of cell cycle progression, DNA damage repair, and cell survival.

DIPK2B has also been shown to be involved in metabolism and energy homeostasis. It is a component of the mitochondrial inner membrane, where it is involved in the transfer of electrons in the electron transport chain. DIPK2B has also been shown to be involved in the regulation of lipid metabolism and to contribute to the maintenance of cellular membrane stability.

Potential Drug Target and Biomarker

DIPK2B has been identified as a potential drug target due to its involvement in various cellular processes that are critical for human health and disease. The DIPK2B protein is a non-synonymous splicing isoform, which means that it has the potential to generate unique drug targets that are not present in the parent isoforms.

One potential drug target for DIPK2B is the inhibition of its activity, which could lead to the inhibition of the RAS/MAPK signaling pathway and the regulation of cellular processes that are critical for cell survival. This could be useful for the treatment of various diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

Another potential drug target for DIPK2B is the modulation of its expression levels, which could be useful for the regulation of cellular processes that are critical for

Protein Name: Divergent Protein Kinase Domain 2B

The "DIPK2B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DIPK2B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets